ClinicalTrials.Veeva

Menu

Clinical, Electrophysiological and E-field Modelling Evidence of High Density Transcranial Direct Current Stimulation in Motor Stroke (E-brain)

X

Xavier Corominas

Status

Unknown

Conditions

Stroke

Treatments

Device: high definition transcranial direct current stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT05329818
077/2021

Details and patient eligibility

About

The present study aims to investigate the therapeutic potential of a high definition transcranial direct current stimulation protocol, stimulating frontal and cerebellar areas boosting the cognitive and motor recovery of stroke population.

Full description

Stroke cause direct network dysfunctions correlating with the underlying behavioral deficits In that context, characterize and boost neuronal reshaping towards a favorable state for recovery has become a distinguished therapeutic approach. Transcranial direct current stimulation (tDCS) is a non-invasive brain stimulation able to locally modulate neuronal activity and modify neural arquitecture.

In such scenario, the investigators develop in this protocol a new tDCS multitarget fronto-cerebellar tDCS approach, exploring the benefits of boosting motor dysfunctions by means of a dual site-approach, up-regulating dlPFC and CB activity. The investigators here design a pilot experimental clinical trial exploring the accumulative clinical potential for motor skill & learning recovery and EEG effects of a high-density bifocal transcranial direct current stimulation protocol (HD-tDCS).

The investigators hypothesize that the tDCS protocol will promote direct functional motor reorganization helping relearning motor process, will boost the activity of prefrontal settled systems correcting attentional deficits and increasing strength connectivity with premotor systems, and will normalize large-scale abnormalities increasing interhemispheric functional connectivity (i.e., functional integration), decreasing interhemispheric asymmetry (i.e., functional segregation) and restoring transcallosal balance, impacting positively either in motor and cognitive recovery. All in all, this study will be the first exploring the simultaneous modulation of two different targets in stroke population corresponding to different networks looking for a summative/synergistic effects helping motor and cognitive functions recovery.

Enrollment

40 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Received a diagnosis of supratentorial ischemic or hemorrhagic stroke confirmed by neuroimage (MRI, PET, CT, fMRI or DTI) in the middle cerebral artery territory or encompassing fronto-temporo-parietal hemorrhages
  • Enrolled in a live rehabilitation program in the rehabilitation and physical medicine department
  • Between 4 and 12 months after stroke episode
  • Have signed the informed form

Exclusion criteria

  • Medical instability with the presence of infections, assisted ventilation, epilepsy or recurrent seizures, untreated psychiatric disorders or an active treatment with sedative drugs
  • tDCS contraindications as defined by the international safety guidelines
  • Large aphasic, psychiatric and cognitive deficits limiting patient's comprehension

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

40 participants in 4 patient groups

Prefrontal stimulation.
Experimental group
Description:
Participants receive anodal tDCS on the ipsilesional dlPFC for 5days/week for 2 weeks.
Treatment:
Device: high definition transcranial direct current stimulation
Cerebellar stimulation.
Experimental group
Description:
Participants receive anodal tDCS on the contralesional cerebellum for 5days/week for 2 weeks. min of HD-tDCS with 2.0mA.
Treatment:
Device: high definition transcranial direct current stimulation
Fronto-cerebellar stimulation.
Experimental group
Description:
Participants receive simultaneous anodal tDCS on the ipsilesional dlPFC and in contralesional cerebellum for 5days/week for 2 weeks.
Treatment:
Device: high definition transcranial direct current stimulation
Sham stimulation.
Sham Comparator group
Description:
Participants receive sham tDCS for 5days/week for 2 weeks.
Treatment:
Device: high definition transcranial direct current stimulation

Trial contacts and locations

1

Loading...

Central trial contact

Maria Teresa Colomina Fosch, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems